Isoxsuprine

Active ingredient: Isoxsuprine Hydrochloride

In short: Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows: For the relief of symptoms associated with cerebrovascular insufficiency. In peripheral vascular disease of arteriosclerosis obliterans, t

LabelVedco dba Valdar
Label updatedFeb 07, 2012

What is Isoxsuprine used for?

Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:

For the relief of symptoms associated with cerebrovascular insufficiency.

In peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (Buerger's disease) and Raynaud's disease.

Final classification of the less-than-effective indications requires further investigation.

Isoxsuprine dosage

Oral: 10 to 20 mg, three or four times daily.

Warnings & precautions

Do not take this medicine if: There are no known contraindications to oral use when administered in recommended doses.

Isoxsuprine Hydrochloride, USP should not be given immediately postpartum or in the presence of arterial bleeding.

Safety and effectiveness in pediatric patients has not been established.

Isoxsuprine side effects

On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.

Although available evidence suggests a temporal association of these reactions with Isoxsuprine Hydrochloride, a causal relationship can be neither confirmed nor refuted.

Beta Adrenergic receptor stimulants such as Isoxsuprine Hydrochloride have been used to inhibit pre-term labor.

Maternal and fetal tachycardia may occur under such use.

Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received Isoxsuprine Hydrochloride. Pulmonary edema has been reported in mothers treated with beta stimulants. Isoxsuprine Hydrochloride is neither approved nor recommended for use in the treatment of premature labor.

About this medicine

Each tablet taken orally contains Isoxsuprine Hydrochloride, USP with the following chemical structure:

p-Hydroxy-α[1-[(methyl-2-phenoxy-ethyl)amino]ethyl]benzyl alcohol hydrochloride.

Each tablet taken orally contains 20mg Isoxsuprine Hydrochloride.

Peripheral Vasodilator

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 908691b4-7950-4f3e-bbea-ea568fee7ac3. Read the full official label on DailyMed.